SCHEMBL1654530

SCHEMBL1654530

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4C[C@H](OS(=O)(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
VDR P11473 2/20 0.77
ABCC4 O15439 2/20 0.77
GPBAR1 Q8TDU6 9/20 0.72
NR1H4 Q96RI1 4/20 0.72
MEN1 O00255 2/20 0.72
KMT2A Q03164 2/20 0.72
ABCB11 O95342 2/20 0.72
SLC10A2 Q12908 2/20 0.72
SLC10A1 Q14973 2/20 0.72
LMNA P02545 1/20 0.72
CYP2C19 P33261 1/20 0.72
CHRM2 P08172 1/20 0.72
ADRA2A P08913 1/20 0.72
ADRA1A P35348 1/20 0.72
TDP1 Q9NUW8 1/20 0.72
ENPP2 Q13822 1/20 0.72
CISD1 Q9NZ45 1/20 0.72
CYP3A4 P08684 1/20 0.72
ABCC1 P33527 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18280265 1.00 VDR (0.77) VDRABCC4GPBAR1NR1H4MEN1
SCHEMBL18280267 1.00 VDR (0.77) VDRABCC4GPBAR1NR1H4MEN1
SCHEMBL28901763 1.00 VDR (0.77) VDRABCC4GPBAR1NR1H4MEN1
SCHEMBL1655224 1.00 VDR (0.77) VDRABCC4GPBAR1NR1H4MEN1
SCHEMBL19360936 0.93 VDR (0.77) VDRABCC4GPBAR1NR1H4MEN1
Ursulcholic Acid SCHEMBL5683101 0.92 GPBAR1 (0.72) VDRABCC4GPBAR1NR1H4MEN1
Ursulcholic Acid SCHEMBL27095060 0.91 ABCC4 (0.77) VDRABCC4GPBAR1NR1H4MEN1
Ursulcholic Acid SCHEMBL2919469 0.91 ABCC4 (0.77) VDRABCC4GPBAR1NR1H4MEN1
Ursulcholic Acid SCHEMBL6269998 0.91 ABCC4 (0.77) VDRABCC4GPBAR1NR1H4MEN1
SCHEMBL232879 0.91 ABCC4 (0.79) VDRABCC4GPBAR1NR1H4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023233945-A1 BILIARY TRACT CANCER TESTING METHOD 株式会社日立ハイテク 2023-12-07 WO claimed
WO-2023233945-A1 BILIARY TRACT CANCER TESTING METHOD 株式会社日立ハイテク 2023-12-07 WO disclosed
US-20140234398-A1 Dissolution of Arterial Plaque ATHERONOVA OPERATIONS, INC. (US) 2014-08-21 US disclosed
US-20140148422-A1 TREATMENT OF GLUCOSE INTOLERANCE ATHERONOVA OPERATIONS, INC. (US) 2014-05-29 US disclosed
US-20140142071-A1 REGRESSION OF ARTERIAL PLAQUE ATHERONOVA OPERATIONS, INC. (US) 2014-05-22 US disclosed
US-8697633-B2 Dissolution of arterial plaque ATHERONOVA OPERATIONS, INC. (US) 2014-04-15 US disclosed
US-20130029946-A1 DISSOLUTION OF ARTERIAL PLAQUE ATHERANOVA OPERATIONS, INC. (US) 2013-01-31 US disclosed
US-8304383-B2 Atherosclerosis therapy ; circulation of emulsifiers; using bile salts, saponins or detergent surfactant; concurrent administering with statin ATHERONOVA OPERATIONS, INC. (US) 2012-11-06 US disclosed
EP-2485738-A2 COMPOSITIONS AND METHODS FOR TREATING OBESITY Atheronova Operations, Inc. (US) 2012-08-15 EP disclosed
WO-2011044523-A2 COMPOSITIONS AND METHODS FOR TREATING OBESITY ATHERONOVA OPERATIONS, INC. (US) 2011-04-14 WO disclosed
WO-2010033637-A1 DISSOLUTION OF ARTERIAL PLAQUE Z & Z MEDICAL HOLDINGS, INC. (US) 2010-03-25 WO disclosed
US-20090035348-A1 DISSOLUTION OF ARTERIAL PLAQUE Z & Z MEDICAL HOLDINGS, INC. (US) 2009-02-05 US disclosed
WO-2008144458-A1 DISSOLUTION OF ARTERIAL CHOLESTEROL PLAQUES BY PHARMACOLOGICALLY INDUCED ELEVATION OF ENDOGENOUS BILE SALTS Z & Z MEDICAL HOLDINGS, INC. (US) 2008-11-27 WO disclosed
US-20080287429-A1 Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts Z & Z MEDICAL HOLDINGS, INC. (US) 2008-11-20 US disclosed
US-20080187569-A1 DISSOLUTION OF ARTERIAL PLAQUE Z & Z MEDICAL HOLDINGS, INC. (US) 2008-08-07 US disclosed
US-20070129425-A1 Dissolution of arterial cholesterol plaques by pharmacological preparation Z & Z MEDICAL HOLDINGS, INC. 2007-06-07 US disclosed
WO-2007061820-A2 DISSOLUTION OF ARTERIAL CHOLESTEROL PLAQUES BY A CLASS OF PHARMACOLOGICAL COMPOUNDS ZADINI FILIBERTO (US) 2007-05-31 WO disclosed
US-20070116754-A1 Dissolution of arterial cholesterol plaques by pharmacological preparation Z & Z MEDICAL HOLDINGS, INC. 2007-05-24 US disclosed
US-20070116755-A1 Dissolution of arterial cholesterol plaques by pharmacological preparation Z & Z MEDICAL HOLDINGS, INC. 2007-05-24 US disclosed
US-20070071706-A1 Lipodissolving dermatological topical preparation ATHERONOVA OPERATIONS, INC. 2007-03-29 US disclosed